PMD Solutions launches Medtech product RespiraSense

PMD Solutions launches Medtech product RespiraSense at the 12th International Conference on Rapid Response Systems and Medical Emergency Teams in Melbourne May 2nd 2016

 

PMD Solutions, an SME based in Cork, Ireland, is committed to “make every breath count” while reducing the cost of healthcare in the acute medical setting.

Myles Murray, (CEO – PMD Solutions) engaged the International Conference on Rapid Response Systems and Medical Emergency teams today with his vision of how the technology of “RespiraSense” (from PMD Solutions) will positively impact the future of Global Healthcare.

‘RespiraSense’ is the world’s first continuous and accurate discrete sensor that measures the ‘mechanics of respiration’. This gives medical staff the earliest signs of possible patient deterioration from conditions such as respiratory compromise, increasing severity of sepsis, worsening pneumonia, and oncoming heart attacks. The device, a discrete wireless sensor, is ideally designed for general ward patients who are at risk of adverse events until discharge.

Mr. Murray stated “PMD is excited to ‘make every breath count’ for acute medical patients while providing clinicians important and timely trending information to help prevent in-hospital adverse events. As Respiratory rate is a key indicator of a patients general well-being so changes in this vital sign can provide indications of respiratory compromise. This technology supports global (Early Warning Score) initiatives while also providing a boost towards the implementation of digital (and paperless) healthcare”.

‘RespiraSense’ is designed to continuously measure this vital sign, which if detected to be abnormal can help medical staff prevent these from happening with patients on the general ward. This can result in better patient outcomes and overall reduce length of stay for patients in hospitals and to free up beds – a current need for ICU and Emergency Departments globally”.

PMD Solutions is currently collaborating with some of the largest research hospitals across Europe, the U.S and Asia to demonstrate the positive outcomes from continuous monitoring of respiration rate.

Contact:

Prism PR: Julienne Curran – Director;
(jcurran@prismpr.ie ; +353 (86) 441 5722)

PMD Solutions: Dave Sheppard, Chief Marketing Officer
(dave.sheppard@pmd-solutions.com ; +1 978 684 2712)

Recent Posts